New hope for Cushing's patients: drug targets tough hypertension
NCT ID NCT07247162
First seen Jan 10, 2026 · Last updated May 23, 2026 · Updated 19 times
Summary
This study tests a drug called osilodrostat in 63 adults with Cushing's syndrome who also have high blood pressure. The goal is to see if the drug can safely lower both cortisol levels and blood pressure over 30 weeks. Participants will receive either the drug or a placebo, and blood pressure will be monitored closely.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.